Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8

被引：0
|
作者：
Junwei Huang
Eoon Hye Ji
Xinyuan Zhao
Li Cui
Kaori Misuno
Mian Guo
Zhigang Huang
Xiaohong Chen
Shen Hu
机构：
[1] University of California,School of Dentistry
[2] University of California,Jonsson Comprehensive Cancer Center
[3] Capital Medical University,Department of Otorhinolaryngology, Key Laboratory of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital
[4] Southern Medical University,Department of Endodontics, Stomatological Hospital
[5] The Second Affiliated Hospital of Harbin Medical University,Department of Neurosurgery
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
Head and neck squamous cell carcinoma; SOX11; SDCCAG8; Proteomics; Invasion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer
    Hai-yan Piao
    Jing-Lei Qu
    Yun-Peng Liu
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 441 - 449
  • [42] SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer
    Piao, Hai-yan
    Qu, Jing-Lei
    Liu, Yun-Peng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (04) : 441 - 449
  • [43] Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway (vol 8, pg 921, 2018)
    Qin, Xing
    Yan, Ming
    Wang, Xu
    Xu, Qin
    Wang, Xiaoning
    Zhu, Xueqin
    Shi, Jianbo
    Li, Zhihui
    Zhang, Jianjun
    Chen, Wantao
    THERANOSTICS, 2022, 12 (04): : 1730 - 1731
  • [44] HOXC6 promotes cervical cancer progression via regulation of Bcl-2
    Wang, Yongsheng
    Wang, Cong
    Liu, Na
    Hou, Jun
    Xiao, Wenjing
    Wang, Hui
    FASEB JOURNAL, 2019, 33 (03): : 3901 - 3911
  • [45] Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
    Jin Li
    Zhongwu Li
    Yaping Wu
    Yanling Wang
    Dongmiao Wang
    Wei Zhang
    Hua Yuan
    Jinhai Ye
    Xiaomeng Song
    Jianrong Yang
    Hongbing Jiang
    Jie Cheng
    Cell Death & Disease, 15 (12)
  • [46] Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway
    Qin, Xing
    Yan, Ming
    Wang, Xu
    Xu, Qin
    Wang, Xiaoning
    Zhu, Xueqin
    Shi, Jianbo
    Li, Zhihui
    Zhang, Jianjun
    Chen, Wantao
    THERANOSTICS, 2018, 8 (04): : 921 - 940
  • [47] Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer
    Figueroa-Gonzalez, Gabriela
    Carrillo-Hernandez, Jose F.
    Perez-Rodriguez, Itzel
    Cantu de Leon, David
    Campos-Parra, Alma D.
    Martinez-Gutierrez, Antonio D.
    Coronel-Hernandez, Jossimar
    Garcia-Castillo, Veronica
    Lopez-Camarillo, Cesar
    Peralta-Zaragoza, Oscar
    Jacobo-Herrera, Nadia J.
    Guardado-Estrada, Mariano
    Perez-Plasencia, Carlos
    GENES, 2020, 11 (09) : 1 - 17
  • [48] Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation
    Chang, Wei-Min
    Lin, Yuan-Feng
    Su, Chia-Yi
    Peng, Hsuan-Yu
    Chang, Yu-Chan
    Hsiao, Jenn-Ren
    Chen, Chi-Long
    Chang, Jang-Yang
    Shieh, Yi-Shing
    Hsiao, Michael
    Shiah, Shine-Gwo
    SCIENTIFIC REPORTS, 2017, 7
  • [49] Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation
    Wei-Min Chang
    Yuan-Feng Lin
    Chia-Yi Su
    Hsuan-Yu Peng
    Yu-Chan Chang
    Jenn-Ren Hsiao
    Chi-Long Chen
    Jang-Yang Chang
    Yi-Shing Shieh
    Michael Hsiao
    Shine-Gwo Shiah
    Scientific Reports, 7
  • [50] CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance
    Sun, Wan-Hsuan
    Peng, Ta-Jung
    Tang, Shye-Jye
    Lin, Jo-Yu
    Wang, Chia-Yi
    Fang, Hsueh-Jou
    Sun, Kuang-Hui
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2022, 51 (09) : 791 - 800
12345